🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
January 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — January 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1606)
All (1606)
Buys (146)
Sells (1460)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
RAPID MICRO BIOSYSTEMS, INC.
(RPID)
Longitude Capital Partners II, LLC
— 10% Owner
Jan 30, 2026
Sale
Shares
46,000
Price
$4.54
Total Value
$209.00K
Shares Held After
104,000
% of Holdings
30.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
TCG Crossover GP II, LLC
— 10% Owner
Jan 30, 2026
Purchase
Shares
2,135
Price
$21.39
Total Value
$45.67K
Shares Held After
639,140
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Surrozen, Inc./DE
(SRZN)
TCG Crossover GP II, LLC
— 10% Owner
Jan 30, 2026
Purchase
Shares
2,136
Price
$21.39
Total Value
$45.69K
Shares Held After
639,141
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Centessa Pharmaceuticals plc
(CNTA)
HUSSAIN IQBAL J
— Chief Legal Officer
Jan 30, 2026
Sale
Shares
1,010
Price
$25.01
Total Value
$25.26K
Shares Held After
104,376
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
Baroldi Joseph
— EVP, Chief Business Officer
Jan 30, 2026
Sale
Shares
5,296
Price
$82.96
Total Value
$439.36K
Shares Held After
45,413
% of Holdings
10.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
Birchler Brian
— EVP, Corp and Development Ops
Jan 30, 2026
Sale
Shares
6,179
Price
$83.03
Total Value
$513.05K
Shares Held After
66,247
% of Holdings
8.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
O'NEIL PATRICK R.
— EVP CLO & General Counsel
Jan 30, 2026
Sale
Shares
6,179
Price
$83.53
Total Value
$516.15K
Shares Held After
71,983
% of Holdings
7.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
HOUGEN ELIZABETH L
— EVP, Finance & CFO
Jan 30, 2026
Sale
Shares
6,988
Price
$83.24
Total Value
$581.70K
Shares Held After
132,881
% of Holdings
5.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
BENNETT C FRANK
— EVP, Chief Scientific Officer
Jan 30, 2026
Sale
Shares
5,885
Price
$82.95
Total Value
$488.14K
Shares Held After
100,293
% of Holdings
5.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
Schneider Eugene
— EVP, Chf Clinical Develop Ofcr
Jan 30, 2026
Sale
Shares
6,179
Price
$83.45
Total Value
$515.63K
Shares Held After
69,702
% of Holdings
8.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
Swayze Eric
— EVP Research
Jan 30, 2026
Sale
Shares
6,179
Price
$82.93
Total Value
$512.45K
Shares Held After
47,747
% of Holdings
11.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
IONIS PHARMACEUTICALS INC
(IONS)
Monia Brett P
— Director
Jan 30, 2026
Sale
Shares
62,970
Price
$82.72
Total Value
$5.21M
Shares Held After
283,927
% of Holdings
18.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Royalty Pharma plc
(RPRX)
Urist Marshall
— EVP, Research & Investments
Jan 30, 2026
Sale
Shares
20,000
Price
$41.09
Total Value
$821.81K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ELUTIA INC.
(ELUT)
RAKIN KEVIN
— Director
Jan 30, 2026
Purchase
Shares
70,000
Price
$1.06
Total Value
$74.20K
Shares Held After
196,120
% of Holdings
35.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
InspireMD, Inc.
(NSPR)
Gleason Shane Thomas
— Chief Commercial Officer
Jan 30, 2026
Sale
Shares
2,900
Price
$1.63
Total Value
$4.73K
Shares Held After
1,141,177
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Clene Inc.
(CLNN)
Ugwumba Chidozie
— 10% Owner
Jan 30, 2026
Sale
Shares
5,686
Price
$4.13
Total Value
$23.48K
Shares Held After
559,359
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ZEVRA THERAPEUTICS, INC.
(ZVRA)
Quartel Adrian W
— Chief Medical Officer
Jan 30, 2026
Sale
Shares
4,533
Price
$8.83
Total Value
$40.04K
Shares Held After
9,723
% of Holdings
31.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ZEVRA THERAPEUTICS, INC.
(ZVRA)
Schafer Joshua
— CCO
Jan 30, 2026
Sale
Shares
3,375
Price
$8.83
Total Value
$29.80K
Shares Held After
37,444
% of Holdings
8.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ZEVRA THERAPEUTICS, INC.
(ZVRA)
Thompson Rahsaan
— Chief Legal & Compliance
Jan 30, 2026
Sale
Shares
4,080
Price
$8.83
Total Value
$36.01K
Shares Held After
49,919
% of Holdings
7.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ZEVRA THERAPEUTICS, INC.
(ZVRA)
Sangiovanni Timothy J.
— SVP, Finance & Corp Controller
Jan 30, 2026
Sale
Shares
1,750
Price
$8.82
Total Value
$15.44K
Shares Held After
20,924
% of Holdings
7.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Beam Therapeutics Inc.
(BEAM)
Evans John M.
— Director
Jan 30, 2026
Sale
Shares
2,906
Price
$29.00
Total Value
$84.27K
Shares Held After
986,667
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Beam Therapeutics Inc.
(BEAM)
Evans John M.
— Director
Jan 30, 2026
Sale
Shares
22,094
Price
$28.27
Total Value
$624.67K
Shares Held After
989,573
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Aprea Therapeutics, Inc.
(APRE)
Hamill John P.
— SrVP/CFO/Prin Fin & Acct Ofcr
Jan 30, 2026
Purchase
Shares
5,700
Price
$0.89
Total Value
$5.07K
Shares Held After
33,433
% of Holdings
17.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Aprea Therapeutics, Inc.
(APRE)
Gilad Oren
— Director
Jan 30, 2026
Purchase
Shares
28,100
Price
$0.89
Total Value
$25.01K
Shares Held After
373,720
% of Holdings
7.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PHIBRO ANIMAL HEALTH CORP
(PAHC)
BENDHEIM JACK
— Director
Jan 30, 2026
Sale
Shares
6,693
Price
$40.09
Total Value
$268.35K
Shares Held After
31,980
% of Holdings
17.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Planet 13 Holdings Inc.
(PLNH)
Wren Chris
— VP of Operations
Jan 30, 2026
Sale
Shares
25,000
Price
$0.17
Total Value
$4.37K
Shares Held After
3,848,287
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ELUTIA INC.
(ELUT)
NEELS GUIDO J
— Director
Jan 30, 2026
Purchase
Shares
20,000
Price
$1.04
Total Value
$20.80K
Shares Held After
118,750
% of Holdings
16.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Malenka Robert C.
— Director
Jan 30, 2026
Sale
Shares
6,612
Price
$18.11
Total Value
$119.74K
Shares Held After
365,273
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
Hansen Gwenn
— Chief Scientific Officer
Jan 30, 2026
Sale
Shares
98
Price
$17.37
Total Value
$1.70K
Shares Held After
83,672
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
Hansen Gwenn
— Chief Scientific Officer
Jan 30, 2026
Sale
Shares
4,797
Price
$16.58
Total Value
$79.55K
Shares Held After
83,770
% of Holdings
5.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
van Houte Hans
— Chief Financial Officer
Jan 30, 2026
Sale
Shares
73
Price
$17.37
Total Value
$1.27K
Shares Held After
45,427
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
van Houte Hans
— Chief Financial Officer
Jan 30, 2026
Sale
Shares
3,588
Price
$16.58
Total Value
$59.50K
Shares Held After
45,500
% of Holdings
7.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
Ring Christine
— Chief Legal Officer
Jan 30, 2026
Sale
Shares
88
Price
$17.37
Total Value
$1.53K
Shares Held After
57,010
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
Ring Christine
— Chief Legal Officer
Jan 30, 2026
Sale
Shares
4,333
Price
$16.58
Total Value
$71.85K
Shares Held After
57,098
% of Holdings
7.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
DAVITA INC.
(DVA)
BERKSHIRE HATHAWAY INC
— 10% Owner
Jan 29, 2026
Sale
Shares
1,658,480
Price
$120.56
Total Value
$199.94M
Shares Held After
30,100,585
% of Holdings
5.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
InspireMD, Inc.
(NSPR)
Gleason Shane Thomas
— Chief Commercial Officer
Jan 29, 2026
Sale
Shares
5,000
Price
$1.65
Total Value
$8.25K
Shares Held After
1,144,077
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Clene Inc.
(CLNN)
Ugwumba Chidozie
— 10% Owner
Jan 29, 2026
Sale
Shares
15,284
Price
$4.32
Total Value
$66.03K
Shares Held After
565,045
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
DBV Technologies S.A.
(DBVT)
Mohideen Pharis
— Chief Medical Officer
Jan 29, 2026
Sale
Shares
534
Price
$4.86
Total Value
$2.60K
Shares Held After
144,995
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nuvalent, Inc.
(NUVL)
Noci Darlene
— Chief Development Officer
Jan 29, 2026
Sale
Shares
63
Price
$103.39
Total Value
$6.51K
Shares Held After
58,117
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nuvalent, Inc.
(NUVL)
Noci Darlene
— Chief Development Officer
Jan 29, 2026
Sale
Shares
1,819
Price
$102.67
Total Value
$186.76K
Shares Held After
58,180
% of Holdings
3.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nuvalent, Inc.
(NUVL)
Noci Darlene
— Chief Development Officer
Jan 29, 2026
Sale
Shares
3,429
Price
$101.80
Total Value
$349.07K
Shares Held After
59,999
% of Holdings
5.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nuvalent, Inc.
(NUVL)
Noci Darlene
— Chief Development Officer
Jan 29, 2026
Sale
Shares
189
Price
$100.95
Total Value
$19.08K
Shares Held After
63,428
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Beam Therapeutics Inc.
(BEAM)
Evans John M.
— Director
Jan 29, 2026
Sale
Shares
8,667
Price
$29.74
Total Value
$257.78K
Shares Held After
986,667
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Beam Therapeutics Inc.
(BEAM)
Evans John M.
— Director
Jan 29, 2026
Sale
Shares
16,333
Price
$29.19
Total Value
$476.80K
Shares Held After
995,334
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PHIBRO ANIMAL HEALTH CORP
(PAHC)
BENDHEIM JACK
— Director
Jan 29, 2026
Sale
Shares
6,772
Price
$40.12
Total Value
$271.69K
Shares Held After
38,673
% of Holdings
14.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Maze Therapeutics, Inc.
(MAZE)
Dandekar Atul
— CSBO
Jan 29, 2026
Sale
Shares
2,800
Price
$45.01
Total Value
$126.02K
Shares Held After
10,503
% of Holdings
21.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Maze Therapeutics, Inc.
(MAZE)
Dandekar Atul
— CSBO
Jan 29, 2026
Sale
Shares
3,500
Price
$44.04
Total Value
$154.15K
Shares Held After
13,303
% of Holdings
20.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Maze Therapeutics, Inc.
(MAZE)
Dandekar Atul
— CSBO
Jan 29, 2026
Sale
Shares
1,200
Price
$43.18
Total Value
$51.82K
Shares Held After
16,803
% of Holdings
6.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Malenka Robert C.
— Director
Jan 29, 2026
Sale
Shares
21,262
Price
$18.55
Total Value
$394.41K
Shares Held After
371,885
% of Holdings
5.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INTUITIVE SURGICAL INC
(ISRG)
Curet Myriam
— EVP & Chief Medical Officer
Jan 29, 2026
Sale
Shares
126
Price
$520.02
Total Value
$65.52K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Next →
Showing 1–50 of 1606 transactions (page 1 of 33)
Version: v26.3.23